Role of autocrine motility factor in a 12-lipoxygenase dependent anti-apoptotic pathway.
Tang
K
K
Department of Radiation Oncology, Wayne State University School of Medicine, Detroit, MI 48202, USA.
Nie
D
D
Honn
K V
KV
D000577:Amides / Q000494:pharmacology; D017209:Apoptosis / Q000187:drug effects / Q000502:physiology*; D001092:Arachidonate 12-Lipoxygenase / Q000235:genetics / Q000502:physiology*; D001596:Benzylamines / Q000494:pharmacology; D053148:Caspase 3; D020169:Caspases / Q000378:metabolism; D004789:Enzyme Activation / Q000187:drug effects; D015870:Gene Expression / Q000187:drug effects; D005956:Glucose-6-Phosphate Isomerase / Q000494:pharmacology / Q000502:physiology*; D006801:Humans; D016859:Lipoxygenase Inhibitors / Q000494:pharmacology; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D014407:Tumor Cells, Cultured
D000577:Amides; D001596:Benzylamines; D016859:Lipoxygenase Inhibitors; D012333:RNA, Messenger; C085219:N-benzyl-N-hydroxy-5-phenylpentamide; D001092:Arachidonate 12-Lipoxygenase; C505407:CASP3 protein, human; D053148:Caspase 3; D020169:Caspases; D005956:Glucose-6-Phosphate Isomerase